Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Clark & Elbing LLP patentsThe following is a sampling of recent Clark & Elbing LLP patent applications (USPTO Patent Application #, Patent Title) sorted by month.
February 2011 - Clark & Elbing LLP patents
20110045025 - Pharmaceutical compositions containing clostridium difficile toxoids a and b
20110045058 - Transfection reagent
20110045518 - Ykl-40 as a general marker for non-specific disease
20110046083 - Activators of pyruvate kinase m2 and methods of treating disease
20110046107 - Sulfonyl-substituted carbapenem compounds
20110038795 - Targeted radiotherapy
20110038935 - Antibodies against influenza virus and methods of use thereof
20110039718 - Methods for identification of jak kinase interacting molecules and for the purification of jak kinases
20110039785 - Polypeptide-nucleic acid conjugates and uses thereof
20110033474 - Inhibition of platelet aggregation
20110033951 - Assay method and kit for nucleic acid binding protein
20110034446 - R(-)-2-methoxy-11-hydroxyaporphine and derivatives thereof
20110027182 - Substance for obtaining highly effective tumor medications as well as a process
20110027293 - Methods and compositions for the inhibition of viral infection by targeting intracellular trafficking
20110027332 - Pliable medical device and method of use
20110027377 - Immediate release pharmaceutical granule compositions and a continuous process for making them
20110028293 - Methods for low cost manufacturing of complex layered materials and device
20110028404 - Composition comprising vegetable peptone for promoting stem cell proliferation
20110028564 - Compositions and methods for treatment of filovirus-mediated diseases
January 2011 - Clark & Elbing LLP patents
20110018154 - Preparation method for solid dispersions
20110018538 - Nmr device for detection of analytes
20110020346 - Anti-vegf antibodies
20110020398 - Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis c virus
20110020498 - (arabino)xylan oligosaccharide preparation
20110020787 - Nmr device for detection of analytes
20110020788 - Nmr device for detection of analytes
20110020896 - Mutant dna polymerases and their genes
20110020950 - Scaffold for composite biomimetic membrane
20110020953 - Nmr device for detection of analytes
20110021227 - System and a method for indicating an uplink resource
20110021374 - Nmr device for detection of analytes
20110021919 - High frequency, high frame-rate ultrasound imaging system
20110023137 - Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof
20110014197 - Methods of treating pre-eclampsia or eclampsia
20110014198 - Anti-vegf antibodies
20110014227 - Pre-or post-exposure treatment for filovirus or arenavirus infection
20110014229 - Chimeric flavivirus vectors
20110014232 - Chimeric foot and mouth disease viruses
20110015261 - Use of a composition comprising at least one beta-blocker for the treatment of sleep disorders
20110015946 - Insurance data communication system
20110005536 - Nicotiana diversity
20110008310 - Methods and compositions for mitochondrial replacement therapy
20110008454 - Immediate release pharmaceutical granule compositions and a continuous process for making them
20110008784 - Methods and compositions for identifying undifferentiated stem cells and assessing cell health
20110009328 - Polypeptide derivatives of parathyroid hormone (pth)
20110009481 - Medicament for the treatment of viral skin and tumour diseases
20110009787 - Artificial exoskeleton device or an orthotic device comprising an integrated hinge structure
20110009799 - Antithrombogenic hollow fiber membranes and filters
20110000480 - Administration of interferon for prophylaxis against or treatment of pathogenic infection
20110002688 - system and method for implementing an automatic discovery function in a dwdm network
20110002992 - N-sulphonylated amino acid derivatives, method for the production and use thereof
20110003358 - Cultures of gfap+ nestin+ cells that differentiate to neurons
20110003884 - Viral vectors and methods of use
December 2010 - Clark & Elbing LLP patents
20100330583 - Compositions and methods for identification of parp function, inhibitors, and activators
20100331281 - Phospholipid compositions and uses thereof
20100331524 - Immunomodulatory protein and useful embodiments thereof
20100333216 - Non-human gene-disrupted animal with disrupted adam11 gene
20100322899 - Methods of improving central nervous system functioning
20100322946 - Multispecific antibodies
20100323380 - Methods for diagnosing blood vessel reocclusion
20100323428 - Attenuated minus-stranded rna virus
20100324131 - Salvinorin derivatives and uses thereof
20100316630 - Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use
20100317123 - Method and device for detection of an analyte
20100317701 - Heterocyclic inhibitors of necroptosis
20100317843 - Process for separating biomass components
20100308822 - Small magnet and rf coil for magnetic resonance relaxometry
20100310471 - Antioxidant and paramagnetic heparin-nitroxide derivatives
20100310562 - System for delivery into xcr1 positive cell and uses thereof
20100310574 - Methods and compositions for the treatment and diagnosis of statin-induced myopathy
20100311142 - Novel hydrogenases isolated from thermococcus spp., genes encoding the same, and methods for producing hydrogen using microorganisms having the genes
20100311678 - Methods and compositions for treating cancer and modulating signal transduction and metabolism pathways
20100312846 - Method for releasing buffered data of a serving gateway
20100313062 - method and apparatus for coordinating the system robustness
20100303688 - A storage vessel and a break tool for dividing such vessel
20100303866 - Immunogenic peptides and their use in immune disorders
20100303994 - Method for brewing beer
20100304413 - Diagnostic use of individual molecular forms of a biomarker
20100304472 - Cell culture apparatus and mass automatic cell culture device having it
20100304473 - cell culture flask and the cell culture device having it
20100304474 - Rotation driving device for cell culturing
20100305304 - Non-natural proteinaceous scaffold made of three non-covalently associated peptides
November 2010 - Clark & Elbing LLP patents
20100294850 - Dispensing apparatus
20100297100 - Composition for treating retinopathy or glaucoma comprising thrombin derived peptides
20100297119 - Bone targeted alkaline phosphatase, kits and methods of use thereof
20100297120 - Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
20100297169 - Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications
20100297177 - Mutated parvovirus structural proteins as vaccines
20100297181 - Ampa receptor antagonists for epilepsy, mental disorders or deficits in sensory organ
20100297616 - Situ hybridisation method
20100297645 - Automatic detection of infectious diseases
20100297732 - Vectors with modified protease-dependent tropism
20100298225 - Peptide gap junction modulators
20100298336 - Pyrimidines as novel therapeutic agents
20100298709 - Method for nonlinear imaging of ultrasound contrast agents at high frequencies
20100298760 - Methods, kits, and compositions for administering pharmaceutical compounds
20100291024 - Methods and compositions for the treatment of proliferative and pathogenic diseases
20100291054 - Novel regulatory t cells and uses thereof
20100291237 - Boron-containing compositions
20100291576 - Imprinted genes as epigenetic markers for use in cloning and regenerative cell procedures
20100291677 - Reducer of immunosuppression by tumor cell and antitumor agent using the same
20100292200 - Methods for modulating apoptosis in platelets
20100285044 - Method and compositions for treatment of cancers
20100285056 - Baculovirus-based vaccines
20100286044 - Detection of tissue origin of cancer
20100286184 - Aqueous solution of conophylline and/or conophyllidine
20100286269 - Medium-chain length fatty acids and glycerides as nephroprotection agents
20100287638 - Neural tumor stem cells and methods of use thereof
20100278773 - Chimeric flavivirus vaccines
20100278784 - Methods and compositions for treating skin conditions
20100278854 - Chlamydia antigens
20100280104 - Methods and kits for diagnosis and treatment of cell-cell junction related disorders
20100280220 - Gold binding peptides and shape-and size-tunable synthesis of gold nanostructures
20100280227 - Polypeptides that bind br3 and uses thereof
20100280798 - Tooth movement system and method
October 2010 - Clark & Elbing LLP patents
20100270543 - Biomolecule-based electronic device
20100272689 - Protease having algicidal activity, gene encoding the same and algicidal formulation comprising the same
20100273218 - Compositions and method for storage of nucleic acid from bodily fluids
20100273731 - Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer
20100273998 - Methods and compositions for modulating tissue factor
20100266633 - Aids virus vaccines using sendai virus vector
20100267026 - Methods and apparatus for characterizing polynucleotides
20100267400 - Method for matching group paging of a cdma trunking system
20100260791 - Chlamydia antigens
20100261175 - Use of short oligonucleotides for reagent redundancy experiments in rna functional analysis
20100261707 - Thiadiazole derivatives for the treatment of neurodegenerative diseases
20100262705 - Method and device for transmitting network resource information data
20100255028 - Flavivirus vaccine vector against influenza virus
20100255522 - Screening method utilizing novel substrate epha7 for gamma-secretase
20100256055 - Conjugates of neurotensin or neurotensin analogs and uses thereof
20100256070 - Recombinant vibrio cholerae exotoxins
20100256191 - Ampa receptor antagonists and zonisamide for epilepsy
20100256334 - Peptide aptamers against tenascin c
September 2010 - Clark & Elbing LLP patents
20100247564 - Methods and compositions for the use of sargassum fusiforme for the inhibition of hiv-1 infection
20100247573 - Stabilization of vaccines by lyophilization
20100248244 - Characterization of esm-1 as a tumor associated marker of colorectal cancer
20100248281 - Rapid detection of replicating cells
20100249082 - Modulators of hypoxia inducible factor-1 and related uses
20100251430 - Highly infectious nucleic acid molecules from pepper mottle virus and plant viral vector derived from the same
20100239599 - Vaccine peptide combinations against cat allergy
20100239605 - Recombinant rhinovirus vectors
20100239640 - Skin-derived precursor cells and uses thereof
20100240125 - Bone delivery conjugates and method of using same to target proteins to bone
20100240605 - Novel immunotherapy strategy
20100233009 - Process for producing sintered porous materials
20100233133 - Tissue repair
20100233192 - Manufacturing method of activated lymphocytes for immunotherapy
20100234277 - Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease
20100234454 - Treatment of cnidaria intoxication
20100235932 - Animal models carrying tumors expressing human liver cancer-specific antigen and method for analyzing prevention and treatment efficacy of dendritic cells-derived immunotherapeutics using the above
20100235933 - Kaspp (lrrk2) gene, its production and use for the detection and treatment of neurodegenerative disorders
20100226922 - Specific protease inhibitors and their use in cancer therapy
20100227327 - Methods and compositions for continuous single-molecule nucleic acid sequencing by synthesis with fluorogenic nucleotides
20100227329 - Tools and methods for genetic tests using next generation sequencing
20100227350 - Method of screening substance useful in treating disease with the use of gpr40 and phospholipase
20100228369 - Method and apparatus for automatic support generation for an object made by means of a rapid prototype production method
20100221183 - Peptides for treating and diagnosing cancers and methods for using the same
20100221234 - Bone delivery conjugates and method of using same to target proteins to bone
20100221243 - Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
20100222407 - Triblock copolymers for cytoplasmic delivery of gene-based drugs
20100222296 - Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
20100222354 - Ampa receptor antagonists and aldose reductase inhibitors for neuropathic pain
August 2010 - Clark & Elbing LLP patents
20100209473 - Intraluminal device with a coating containing a therapeutic agent
20100209536 - Methods and kits for use in the treatment and prevention of diseases or conditions of the immune system or infectious diseases
20100209974 - Non-replicating paramyxoviridae virus vector
20100210606 - Methods and reagents for the treatment of inflammatory disorders
20100210733 - Composition for prevention or treatment of bone metabolism disorder comprising d-pinitol as an active ingredient
20100199734 - Method for the production of humus- and nutrient-rich and water-storing soils or soil substrates for sustainable land use and development systems
20100203027 - Viral vector for gene therapy
20100203075 - Chlamydia antigens
20100203083 - Mutated structural protein of a parvovirus
20100203632 - Methods for controlling stem cell differentiation
20100204087 - Tribonectins
20100204105 - Glucagon analogues
20100195657 - Method and system for self-routing in synchronous digital cross-connection
20100196402 - Method for predicting the response of a patient to treatment with an anti-tnf alpha antibody
20100197628 - Methods of treating psychiatric, substance abuse, and other disorders using combinations containing omega-3 fatty acids
20100197703 - N-sulfonyl thiazolylpiperazine derivatives and related n-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases
July 2010 - Clark & Elbing LLP patents
20100189715 - Humanized monoclonal antibodies that protect against shiga toxin induced disease
20100189719 - Anti-vegf antibodies
20100189871 - Biotoxin sorbent and method for preparing the same
20100190729 - Composition for treating atopic dermatitis comprising hirsutanonol or oregonin as an active ingredient
20100190836 - Compounds, screens, and methods of treatment
20100190852 - Short acting phenylalkylamine calcium channel blockers and uses thereof
20100190862 - Composition for treating atopic dermatitis comprising hirsutenone as an active ingredient
20100183630 - Tat-005 and methods of assessing and treating cancer
20100184196 - Composite yeast suitable for high concentration alcohol fermentation from sugar-containing raw materials
20100184214 - Method for production of dendritic cell
20100184644 - Mucosal repair by tff dimer peptides
20100184657 - Methods of treating epithelial lesions outside the stomach and intestines
20100184832 - Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins
20100184804 - Methods for the prevention or treatment of bacterial and fungal infections
20100184974 - Protease inhibitors
20100178283 - Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications
20100179159 - Method for the production of a medicament containing tadalafil
20100179193 - Ampa receptor antagonists and zonisamide for neuropathic pain
20100173881 - Compositions for the treatment of inflammatory disorders
20100166660 - Methods of modeling migraine pain and identifying candidate compounds for the treatment of migraine
20100166705 - Culturing circular ssdna viruses for the production of vaccines
20100166732 - Small streptococcus pyogenes antigens and their use
20100166741 - Altered br-3 binding polypeptides
20100166753 - Humanized monoclonal antibodies that protect against shiga toxin induced disease
20100167341 - Novel protein expression system
20100168174 - Combination of ampa receptor antagonists and acetylcholinesterase inhibitors for the treatment of neuropathic pain
June 2010 - Clark & Elbing LLP patents
20100156244 - Methods for manufacturing ultrasound transducers and other components
20100158867 - Paramyxovirus vector encoding angiogenesis gene and use thereof
20100158916 - Diagnostic biomolecule(s)
20100158938 - Tetravalent dengue vaccines
20100159003 - Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate
20100159228 - Method for preparing a composite material
20100160238 - Tgfp-cap peptide and its uses
20100160455 - Vitamin d3 analogues for the prevention and treatment of bone disorders
20100160491 - Composite particles and methods for their preparation
20100161076 - Orthotic or prosthetic cushioned device and method of making the same
20100150893 - Methods of organ regeneration
20100150915 - Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
20100140112 - Nanoparticle marker, diagnostic methods using the same and diagnostic kit and apparatus using the same
20100143314 - In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
20100143352 - Combination therapy for b cell disorders
20100144550 - Qualitative differential screening
20100144555 - Qualitative differential screening
20100144618 - Compositions containing an intestinal trefoil peptide and a mucoadhesive
20100135997 - Polypeptide monomers and dimers containing mutated ilt
20100136001 - Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
20100136039 - Borrelia antigens
20100136172 - Process for the preparation of angiogenin
20100136246 - Method for producing surfaces and substrates having said surfaces so formed
20100136672 - Cell culture tube and multiple roller tube cell culture apparatus including the same
20100137240 - Use of nucleoside derivatives as anti-koi herpes virus in fish
May 2010 - Clark & Elbing LLP patents
20100129350 - Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives
20100129388 - Protective proteins of s. agalactiae, combinations thereof and methods of using the same
20100129851 - Methods of diagnosing muscle damage
20100130859 - Detection of viable sperm using high frequency ultrasonic imaging
20100130864 - Ultrasonic evaluation of venous structures
20100119512 - Methods of diagnosing, treating, and preventing increased vascular permeability
20100119588 - Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza
20100120146 - Activator of signal transduction pathway
20100120696 - Peptides having activities of epidermal growth factor and its uses
20100120768 - Methods, kits, and compositions for generating new hair follicles and growing hair
20100120849 - Compositions for treating hyperproliferative vascular disorders and cancers
20100111949 - Methods and compositions for the treatment of proliferative diseases
20100113284 - Small interfering rna (sirna) target site blocking oligos and uses thereof
20100113766 - Methods for preparing chlorophyll a and chlorin e6
20100114043 - Hollow type microneedle and methods for preparing it
April 2010 - Clark & Elbing LLP patents
20100105045 - Dnp63a gene and screening methods of anticancer agent by using it
20100105123 - Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
20100098670 - Autologous dental pulp stem cell-based bone graft substitute
20100099737 - Compositions and methods for treating myelosuppression
20100099698 - Compositions for improving skin conditions comprising matrine or its oxidized derivatives
20100099714 - Ampa and nmda receptor antagonists for neurodegenerative diseases
20100099726 - Inhibitors of pyruvate kinase and methods of treating disease
20100099772 - Methods, compositions, and kits for treating pain and pruritis
20100100984 - Transgenic plants exhibiting increased resistance to biotic and abiotic stresses or accelerated flowering time and methods for producing the same
20100092904 - Device for positioning at least one orthodontic element
20100093656 - Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
20100093781 - Imidazo [1, 2-a] pyrrolo [3, 2-c] pyridine compounds useful as pestivirus inhibitors
20100093807 - Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions
20100093860 - Hydroxybutyrate and poly-hydroxybutyrate as components of animal feed or feed additives
20100094382 - Visual prosthesis and methods of creating visual perceptions
20100086564 - West nile virus vaccine
20100087453 - Compounds, screens, and methods of treatment
20100088169 - Methods and webpages for commerce and information exchange
20100081215 - Coating for microcarriers
20100081612 - Polypeptide derivatives of parathyroid hormone (pth)
20100081651 - R(-)-11-hydroxyaporphine derivatives and uses thereof
March 2010 - Clark & Elbing LLP patents
20100074787 - Process for producing sintered porous materials
20100074921 - Carrier
20100068177 - Methods of organ regeneration
20100068190 - Mesoangioblast-like cell as well as methods and uses relating thereto
20100068684 - Method and device for training of a user
20100068715 - Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production
20100070438 - Method for predicting interaction between protein and chemical
20100059438 - Vertical-horizontal filter unit for the biological purification of polluted water
20100062974 - Combination therapy for the treatment of bacterial infections
20100063141 - Deuterated benzylbenzene derivatives and methods of use
20100055068 - Grafted polymers and uses thereof
20100055413 - article, and a method for creating the article, with a chemically patterned surface
20100055711 - Methods for the identification of pi3k interacting molecules and for the purification of pi3k
20100055730 - Methods for the diagnosis and treatment of female infertility using molecular markers
20100055761 - Methods, compositions, and kits for the selective activation of protoxins through combinatoral targeting
20100056456 - Omega conotoxins
20100056488 - Corticosteroid conjugates and uses thereof
20100057368 - Biological systems analysis
20100058097 - Usb based synchronization and timing system
February 2010 - Clark & Elbing LLP patents
20100047246 - Methods and compositions for treating vascular disease
20100047263 - Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
20100047308 - Production methods of virus inactivated and cell-free body implant
20100047894 - Use of matrix metalloproteinases, mutated and not mutated, for the preparation of pharmaceutical compositions, and mutated metalloproteinases with increased stability
20100048422 - Methods of producing modified assembly lines and related compositions
20100048458 - Tribonectins
20100048462 - Truncated pth peptides with a cyclic conformation
20100048545 - Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity
20100037381 - Toilet apparatus
20100040731 - Arabinoxylo-oligosaccharides in beer
20100040996 - Method for manufacturing a prosthesis made prior to implant placement
20100041587 - Combination therapy for inhibition of platelet aggregation
20100041620 - Methods for improving frontal brain bioenergetic metabolism
20100041621 - Methods and compositions for improving cognitive performance
20100041771 - Bioreponsive polymers
20100034796 - Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction
20100034849 - Recombinant bicistronic flavivirus vectors
20100034862 - Covalently grafted pharmaceutically active polymers
20100035221 - Behavior change tool
20100035302 - Method for making soluble arabinoxylans as co-product of fermentation of whole-grain cereals
20100035968 - Mediated cellular delivery of lna oligonucleotides
20100036110 - Methods and compositions for continuous single-molecule nucleic acid sequencing by synthesis with fluorogenic nucleotides
20100028297 - Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
20100028301 - Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
20100028308 - Methods to maintain, improve and restore the cartilage phenotype of chondrocytes
20100028916 - Method for the detection of enzymatic reactions
20100030543 - Products and processes for modulating peptide-peptide binding domain interactions
January 2010 - Clark & Elbing LLP patents
20100021463 - Antibodies to ip-10 for treating bone diseases with bone destruction
20100022109 - Electrical connection apparatus
20100022781 - Trypsin-like serine protease inhibitors, and their preparation and use
20100022807 - Catalytic process for the production of oxygenated hydrocarbons
20100015041 - Class of supramolecular drug molecules and methods of identification and use thereof
20100015071 - Compositions for improving skin conditions comprising alpha-bisabolol as an active ingredient
20100015177 - Method for preserving viral particles
20100015180 - Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses
20100016386 - Selective glycosidase inhibitors and uses thereof
20100008901 - Methods for the treatment and prevention of cancer
20100008990 - Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs
20100009314 - Method and device for placing dental implants
20100009865 - Oligonucleotide arrays
20100009934 - Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders
20100009975 - Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
20100010829 - Employee assistance coaching program
20100001434 - Stamping methods and devices
20100003215 - Culturing circular ssdna viruses for the production of vaccines
20100003227 - Brevibacillus laterosporus strain compositions containing the same and method for the biological control of dipters
20100003672 - Cdna for human methylenetetrahydrofolate reductase and uses thereof
20100004099 - Exercise apparatus and apparel
20100004281 - Viral inhibitors
December 2009 - Clark & Elbing LLP patents
20090324444 - Door opening system
20090324489 - Wortmannin conjugates and uses thereof
20090324548 - Vaccinia virus strains
20090324620 - Conjugates of therapeutic or cytotoxic agents and biologically active peptides
20090326049 - Blocking oligos for inhibition of microrna and sirna activity and uses thereof
20090326078 - Process for preparing a solid dosage form
20090315987 - Rapid detection of replicating cells
20090317329 - Anticoagulation agent and uses thereof
20090317330 - Diagnosis and treatment of diseases involving platelet activation
20090317456 - Use of oncolytic viruses and antiangiogenic agents in the treatment of cancer
20090317474 - Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing
20090318333 - Modified metallothioneins and methods for screening and treatment of diseases associated with oxidative stress
20090318329 - Methods for assessing suitability of cancer patients for treatment with histone deacetylase inhibitors
20090318519 - Process for release of biologically active species
20090318609 - Method for producing a nitrogen functionalised surface
20090319004 - Apparatus and method for stimulating a brain of a person
20090311325 - Enhancing solubility and dissolution rate of poorly soluble drugs
20090311555 - Methof for producing a thiol functionalised coating
20090311803 - Treatment of tumors expressing mutant egf receptors
20090312998 - Real-time monitoring and control of physical and arousal status of individual organisms
20090305224 - Methods for the cryopreservation of mammalian cells
20090305963 - Lipocalin 2 for the treatment, prevention, and management of cancer metastasis, angiogenesis, and fibrosis
20090306222 - Food supplements and uses thereof
20090297504 - Bcma polypeptides and uses thereof
20090297532 - Antibody neutralizers of human granulocyte macrophage colony stimulating factor
20090297593 - Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
20090298927 - Thermal extraction method and product
20090299048 - Reactive pyrophosphoric and bisphosphonic acid derivatives and methods of their use
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Clark & Elbing LLP in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Clark & Elbing LLP with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support - Terms & Conditions
|
REGISTER now for FREE 
